Publication | Closed Access

Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial

Tumor ImmunologyMedicineImmunologyImmune Checkpoint InhibitorImmunotherapy ApproachCancer TreatmentImmunotherapyOncologyRadiation OncologyPlatinum-based Chemotherapy